Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients With Oligometastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Early Interim 18F-FDG-PET and 18F-FLT-PET for Predicting Treatment Response and Survival in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC
- Status
- COMPLETED
- Phase
- PHASE2
Pyrotinib in Combination With Letrozole in Patients With HER2-Positive, ER-Positive Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine
- Status
- UNKNOWN
- Phase
- PHASE2
B002 in Patients With HER2-positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Optimizing Quality of Life in Women Living With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
Pharmacokinetic Study of Pyrotinib and Docetaxel in Combination With Trastuzumab in Patients With HER2 Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics
- Status
- RECRUITING
- Phase
- PHASE1
Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)
- Status
- TERMINATED
- Phase
- PHASE1